MyChoice: An Application of the Three-Factor Eating Questionnaire (TFEQ-R18v2) Among Adolescent and Young Adult Survivors of Central Nervous System (CNS) Tumors
|ClinicalTrials.gov Identifier: NCT01682824|
Recruitment Status : Recruiting
First Posted : September 11, 2012
Last Update Posted : December 13, 2017
The goal of this research study is to learn more about eating practices of survivors of childhood Central Nervous System (CNS) tumors (including brain and spinal cord tumors).
Recent research shows that childhood cancer survivors are experiencing many health issues months or even years after active cancer treatment (for example, irregular blood sugar levels, overweight/obesity, and heart disease). To address this growing concern, researchers at MD Anderson Children's Cancer Hospital and Texas Children's Cancer Center have joined forces to learn more about how to design a program that would promote healthy lifestyles among survivors of childhood cancer.
|Condition or disease||Intervention/treatment|
|Central Nervous System Neoplasms||Behavioral: Three-Factor Eating Questionnaire (TFEQ)-R18v2 Behavioral: Multifactor Screener Behavioral: Eating Questionnaire-EMA (EQ-EMA)|
A one-time assessment will be conducted for all participants through the Assessment Center website. No treatment or intervention will be provided. Two websites will be set up (Site A and Site B). The only difference between the two sites is the order that the questions will appear. The actual questions will remain the same. Only the adolescent and young adult (AYA) survivors of CNS tumors eligible after screening will be invited to respond to the survey. Following the final screening, the eligible participants will be randomized to Site A or Site B.
Each participant will complete the web-based questionnaire that has a total of 53 questions. For site A, the order of the questions will be TFEQ-R18v2, multifactor screener, and EQ-EMA. For site B, the order of the questions will be EQ-EMA, multifactor screener, and TFEQ-R18v2. The 53 questions came from the original TFEQ-R18v2, the multifactor screener used in the National Cancer Institute's Observing Protein and Energy Nutrition Study, and the adapted TFEQ-R18v2 for use via EMA methodology.
Multifactor screener is a short assessment tool used to evaluate dietary intake of fruits, vegetables, percentage of energy from fat, and fiber.
Eating Questionnaire-EMA (EQ-EMA) was adapted based on the original TFEQ-R18v2 for use via EMA methodology. The changes made were related to a change in verbiage to reflect our goal of assessing a participant's current behavior before and after an eating episode.
|Study Type :||Observational|
|Estimated Enrollment :||250 participants|
|Official Title:||MyChoice: An Application of the Three-Factor Eating Questionnaire (TFEQ-R18v2) Among Adolescent and Young Adult Survivors of Central Nervous System (CNS) Tumors|
|Actual Study Start Date :||May 2013|
|Estimated Primary Completion Date :||May 2019|
|Estimated Study Completion Date :||May 2019|
Childhood Central Nervous System (CNS) Tumor Survivors
Questionnaire for Adolescent and young adult (AYA) survivors of childhood central nervous system (CNS) tumors in the United States (US).
Behavioral: Three-Factor Eating Questionnaire (TFEQ)-R18v2
Completion of TFEQ-R18v2 questionnaire.Behavioral: Multifactor Screener
Completion of multifactor screener, a short assessment tool used to evaluate dietary intake of fruits, vegetables, percentage of energy from fat, and fiber.Behavioral: Eating Questionnaire-EMA (EQ-EMA)
Completion of Eating Questionnaire-EMA (EQ-EMA).
- Factor Structure Comparisons of Eating Questionnaires [ Time Frame: 1 day ]Structural equation modeling (SEM) methodology (i.e. confirmatory factor analysis) used to examine extent to which individual items comprising both the original Three Factor Eating Questionnaire-R18v2 (TFEQ-R18v2) and the adapted Eating Questionnaire-Ecological Momentary Assessment (EQ-EMA) loaded on their respective factors cognitive restraint and uncontrollable eating (CR and UE) and will examine the correlations between them. Analyses conducted using Mplus (version 6.12).
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01682824
|Contact: Karen Basen-Engquist, PHD, BA, MPH||713-745-3123|
|Contact: Maria Chang, MPH,RD,LD||713-794-1760||MChang1@mdanderson.org|
|United States, Texas|
|Texas Children's Hospital||Recruiting|
|Houston, Texas, United States, 77030|
|University of Texas MD Anderson Cancer Center||Recruiting|
|Houston, Texas, United States, 77030|
|Contact: MD Anderson Health Information Specialist 877-632-6789|
|Principal Investigator:||Karen Basen-Engquist, PHD, BA, MPH||M.D. Anderson Cancer Center|